Literature DB >> 2477227

Carbohydrate composition of beta-core.

D L Blithe1, R E Wehmann, B C Nisula.   

Abstract

beta-Core is a major component of the hCG-related molecules found in pregnancy urine. We previously have purified the beta-core molecule and have deduced portions of its carbohydrate structure based on lectin binding data. In the present study we used recently developed technology to determine the carbohydrate composition of beta-core and hCG beta (CR119). For direct compositional analysis, parallel samples were hydrolyzed in trifluoroacetic acid and analyzed for sialic acid and neutral sugars without prior derivatization. Separation of the monosaccharides was achieved by HPLC on a Dionex CarboPac column eluted at high pH, and the resolved monosaccharides were quantified by pulsed amperometric detection. The amounts of sugar that were found relative to peptide indicated the presence of two N-linked oligosaccharides per molecule on both beta-core and hCG beta. hCG beta contained additional sugars consistent with the presence of four O-linked oligosaccharides. Compared to hCG beta, beta-core contained negligible sialic acid, galactose, or N-acetylgalactosamine. The compositional data suggest that beta-core does not contain N-acetylglucosamine at the nonreducing end of the molecule, whereas the trimannosyl-chitobiose core is apparently intact at both glycosylation sites, consistent with the ability of the molecule to bind to Concanavalin-A. Comparable fucose contents and abilities of beta-core and hCG beta to bind to Lens culinaris indicate a similar extent of fucosylation on the internal N-acetylglucosamine in both molecules. We propose that the N-linked oligosaccharides on beta-core closely resemble the underlying N-linked structures of hCG beta with the antennary sialic acid, galactose, and N-acetylglucosamine removed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477227     DOI: 10.1210/endo-125-5-2267

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance.

Authors:  Lisa S Kelly; Steven Birken; David Puett
Journal:  Mol Cell Endocrinol       Date:  2006-11-01       Impact factor: 4.102

2.  Patterns of LHbetacf among women in health and disease.

Authors:  Steven Birken; Ruth McChesney; Oksana Yershova; John Gaughan; Kim Pettersson; Geoff Rechenberg; Chung H Wu; George Taliadouros
Journal:  Mol Cell Endocrinol       Date:  2006-11-02       Impact factor: 4.102

3.  Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease.

Authors:  O el-Ahmady; A B Halim; O Mansour; T Salman; A G el-Din; R P Walker
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

4.  Direct analysis of hCGβcf glycosylation in normal and aberrant pregnancy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Ray K Iles; Laurence A Cole; Stephen A Butler
Journal:  Int J Mol Sci       Date:  2014-06-05       Impact factor: 5.923

5.  Characterisation of UGP and its relationship with beta-core fragment.

Authors:  A Kardana; K D Bagshawe; B Coles; D Read; M Taylor
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.